Molecular breeding of allergy vaccines and antiallergic cytokines.
Molecular breeding, also called DNA shuffling, is a technology that enables the generation of large libraries of novel genes and vectors, from which improved variants can be selected based on functional properties. In a common format, it involves recursive recombination and mutation, performed by random fragmentation of related DNA sequences, followed by reassembly of the fragments in a self-priming polymerase chain reaction. As in natural evolution, the technique takes advantage of crossovers, deletions, insertions, inversions and point mutations of genes to generate large pools of related sequences. Molecular breeding can be used to generate improved variants of proteins used as therapeutics, such as vaccine antigens, growth factors and immunomodulatory molecules. Moreover, the technology can be applied to evolve entire viruses or vectors, including DNA vaccines. Cytokines downregulating allergic immune responses and allergens are attractive targets for evolution by molecular breeding. This review describes approaches to generate chimeric allergens with T cell epitopes from multiple allergen homologues, while reducing the recognition by preexisting IgE. In addition, the results and applications of molecular breeding in the evolution of improved antiallergic cytokines are discussed.
Punnonen
J
J
Maxygen, Redwood City, CA 94063, USA.
D000485:Allergens / Q000235:genetics* / Q000276:immunology; D000818:Animals; D016207:Cytokines / Q000235:genetics* / Q000276:immunology / Q000627:therapeutic use*; D003888:Desensitization, Immunologic / Q000379:methods; D005818:Genetic Engineering / Q000379:methods*; D006801:Humans; D019444:Vaccines, DNA / Q000235:genetics* / Q000276:immunology
D000485:Allergens; D016207:Cytokines; D019444:Vaccines, DNA